In this retrospective study, over 60% of the individuals underwent surgical intervention, with three cases receiving a liver transplant and nine unresectable HCC patients undergoing anti-PD1 combination therapy as first-line treatment, presenting a new opportunity to undergo an operation. Here, PDCD1 is linked to hepatocellular carcinoma.